Daniel Pearlstein is an equity research analyst with Eight Capital covering special situations including cannabis, healthcare, and pharmaceuticals.
His previous experience includes analyst roles at a boutique investment bank, a North American healthcare venture capital firm, a medical device startup and a technology transfer incubator.
He holds a bachelor’s degree in chemistry and a master’s degree in management.